| Gilead Sciences, Inc. |
10%+ Owner |
$36.9M |
+$8.17M |
+28.4% |
Nov 26, 2025 |
| Yekaterina Chudnovsky |
10%+ Owner |
$5.32M |
|
|
Jun 7, 2024 |
| SV7 Impact Medicine Fund LP |
10%+ Owner |
$2.68M |
|
|
Oct 26, 2021 |
| Bain Capital Life Sciences Investors, LLC |
10%+ Owner |
$2.33M |
|
|
Dec 8, 2021 |
| James E. Flynn |
Possible Member of 10% Group, 10%+ Owner |
$1.9M |
|
|
Oct 26, 2021 |
| Atlas Venture Fund XI, L.P. |
10%+ Owner |
$1.76M |
|
|
Feb 8, 2024 |
| Fmr Llc |
Other* |
$1.58M |
|
|
Oct 26, 2021 |
| Takeda Pharmaceutical Co Ltd |
10%+ Owner |
$1.22M |
|
|
Oct 26, 2021 |
| RiverVest Venture Fund IV, L.P. |
10%+ Owner |
$1.2M |
|
|
Oct 26, 2021 |
| Rock Springs Capital Management LP |
10%+ Owner |
$1.04M |
|
|
Oct 26, 2021 |
| Bay City Capital Llc |
10%+ Owner |
$937K |
|
|
Oct 26, 2021 |
| Merck KGaA |
10%+ Owner |
$565K |
|
|
Oct 26, 2021 |
| Rene Russo |
PRESIDENT AND CEO, Director |
$329K |
+$24.7K |
+8.1% |
Nov 21, 2025 |
| FIL Ltd |
Other* |
$182K |
|
|
Oct 26, 2021 |
| Alexandria Venture Investments, LLC |
10%+ Owner |
$138K |
|
|
Oct 26, 2021 |
| Simon Tomlinson |
10%+ Owner |
$109K |
|
|
Oct 21, 2021 |
| John Williams |
10%+ Owner |
$83.1K |
|
|
Oct 21, 2021 |
| of Ulrich Rodeck Estate |
10%+ Owner |
$83.1K |
|
|
Oct 21, 2021 |
| Timothy P. Clackson |
10%+ Owner |
$75.5K |
|
|
Oct 21, 2021 |
| Christopher James Frankenfield |
Chief Financial Officer |
$69.4K |
-$6.84K |
-8.97% |
Nov 21, 2025 |
| Katarina Luptakova |
Chief Medical Officer |
$65.4K |
|
|
Nov 21, 2025 |
| James Samuel Shannon |
Director |
$48.2K |
+$48.1K |
+41098% |
Jun 16, 2025 |
| Kevin Brennan |
Svp, Finance And Accounting |
$18.7K |
-$1.77K |
-8.65% |
Nov 21, 2025 |
| Rachel Humphrey |
Director |
$7.84K |
|
|
Oct 21, 2021 |
| Edward C. English |
Principal Accounting Officer |
$4.98K |
|
|
Jan 1, 2023 |
| Michael Jay Ross |
Director |
|
|
|
Jun 15, 2022 |
| Tomas J. Heyman |
Director |
|
|
|
Jun 12, 2023 |
| Christina Rossi |
Director |
|
|
|
Jun 11, 2025 |
| Robert W. Ross |
Director |
|
|
|
Jun 11, 2025 |
| Paul J. Clancy |
Director |
|
|
|
Jun 11, 2025 |
| Daniel Lynch |
Director, 10%+ Owner |
|
|
|
Oct 21, 2021 |
| Salvatore Giovine |
Chief Financial Officer |
|
|
|
Feb 22, 2022 |
| Yuan Xu |
Director |
|
|
|
Jun 11, 2025 |
| Sara Bonstein |
Director |
|
|
|
Jun 11, 2025 |
| Martin H. Huber Jr. |
President And Head Of R&D |
|
|
|
Aug 16, 2023 |
| Daniel J. Curran |
Director |
|
|
|
Jun 11, 2025 |
| Aoife Brennan |
Director |
|
|
|
Jun 11, 2025 |
| Akintunde Olatokumbo Bello |
Director |
|
|
|
Jun 10, 2025 |